BioMed Research International / 2022 / Article / Tab 3 / Research Article
[Retracted] Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses Table 3 Summary of celastrol information.
Drug name Target Symbol Tripterine NR3C1 Glucocorticoid receptor VEGFA Vascular endothelial growth factor A MOL003186 CCND1 G1/S-specific cyclin-D1 BCL2 Apoptosis regulator Bcl-2 BCL2L1 Bcl-2-like protein 1 BAX Apoptosis regulator BAX FLT1 Vascular endothelial growth factor receptor 1 KDR Vascular endothelial growth factor receptor 2 MMP9 Matrix metalloproteinase-9 JUN Transcription factor AP-1 PTGS2 Prostaglandin G/H synthase 2 BIRC5 Baculoviral IAP repeat-containing protein 5 BIRC2 Baculoviral IAP repeat-containing protein 2 CFLAR CASP8 and FADD-like apoptosis regulator AKR1B1 Aldose reductase CDC37 Hsp90 cochaperone Cdc37 MMP2 72 kDa type IV collagenase TIMP1 Metalloproteinase inhibitor 1 TIMP2 Metalloproteinase inhibitor 2 MMP1 Interstitial collagenase MYC Myc proto-oncogene protein FNDC3B Fibronectin COL7A1 Collagen alpha-1 (VII) chain COL4A4 Transforming growth factor beta-1 RELA Collagen alpha-4 (IV) chain